Literature DB >> 18242557

Is the beta3-adrenergic receptor a new target for treatment of post-infarct ventricular tachyarrhythmias and prevention of sudden cardiac death?

Vadim V Fedorov, Ilya T Lozinsky.   

Abstract

Entities:  

Mesh：

Substances：

Year:  2007        PMID： 18242557     DOI： 10.1016/j.hrthm.2007.10.037

Source DB:  PubMed          Journal:  Heart Rhythm        ISSN： 1547-5271            Impact factor:   6.343


× No keyword cloud information.
  2 in total

1.  Optimizing catecholaminergic polymorphic ventricular tachycardia therapy in calsequestrin-mutant mice.

Authors:  Guy Katz; Assad Khoury; Efrat Kurtzwald; Edith Hochhauser; Eyal Porat; Asher Shainberg; Jonathan G Seidman; Christine E Seidman; Abraham Lorber; Michael Eldar; Michael Arad
Journal:  Heart Rhythm       Date:  2010-07-08       Impact factor: 6.343

2.  2D-QSAR and 3D-QSAR/CoMSIA Studies on a Series of (R)-2-((2-(1H-Indol-2-yl)ethyl)amino)-1-Phenylethan-1-ol with Human β₃-Adrenergic Activity.

Authors:  Gastón Apablaza; Luisa Montoya; Cesar Morales-Verdejo; Marco Mellado; Mauricio Cuellar; Carlos F Lagos; Jorge Soto-Delgado; Hery Chung; Carlos David Pessoa-Mahana; Jaime Mella
Journal:  Molecules       Date:  2017-03-05       Impact factor: 4.411
  2 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.